PORTFOLIO

TALENT Biotechs has developed the use of Cannabidiol for the prevention and treatment of GvHD disease, which is a major cause of morbidity and mortality with allogeneic hematopoietic stem cell transplantation. Talent Biotechs was sold and is still the only ‘EXIT’ of a Cannabis company in Israel

Stero Biotechs Ltd., is a clinical-stage company committed to the research and development of novel and improved Cannabidiol (CBD) based treatment solutions that will potentially benefit millions of patients by reducing the side effects and the need of steroidtherapy.

CannaLean Biotechs Ltd., is acompany committed to the research and development of a safe more natural solution for reducing the LDL cholesterol and triglyceride levels without the side effects of currently available therapies. a novel proprietary formulation.

CannaMore is a pre-clinical and clinical stage research platform company committed to the development of novel and improved cannabis-based treatment options that will potentially benefit millions of patients worldwide.

Based on a unique collaboration between CannaMore and BioSeed, NeuroSeed develops an innovative solution to treat the unmet need of Peripheral Neuropathy, a conditions that results from the nerves carrying the signals from the Central Nervous System to the Peripheral Nervous System are damaged or diseased from a wide range of conditions.

Our Start-Ups

We are happy to officially announce,

After another successful graduate has sprung and as of 2021

we are opening our gates to startups interested in joining our seedling program and be apart of the BioSeed family.